Akari Therapeutics, Plc (AKTX) Free cash flow 2016–2023
Akari Therapeutics, Plc (AKTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.4MFY2023 · since FY2016: -$24.7M → -$16.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$16.4M | +24.1% |
| FY2022 | -$21.6M | — |
| FY2019 | -$12.9M | +43.3% |
| FY2018 | -$22.8M | +28.0% |
| FY2017 | -$31.6M | -28.2% |
| FY2016 | -$24.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice